/* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .footer { background: #f5f5f6; color: #555a62; font-size: 14px; line-height: 1.5; padding: 18px 0; } .footer-wrap { padding-left: 18px; padding-right: 18px; max-width: 1236px; margin: 0 auto; } .footer a { color: #0291db; } .footer a:hover { color: #0276b3; } .footer-row { display: flex; flex-wrap: wrap; justify-content: space-between; align-items: center; margin: -3px; } .footer-col { padding: 0 3px; } .footer-col-copyRight { justify-content: flex-start; } .footer-col-logo { justify-content: flex-end; } .footer-col-copyRight, .footer-col-logo { flex: 1; display: flex; } .logo { width: 120px; height: 28px; opacity: 0.6; } @media screen and (max-width: 768px) { .footer-row { display: block; } .footer-col { width: 100%; text-align: center; margin: 6px 0; } .footer-col:first-child { margin-top: 0; } .footer-col:last-child { margin-bottom: 0; } .footer-col-copyRight, .footer-col-logo { justify-content: center; } .logo { margin: 0 auto; } } /*# sourceMappingURL=styles.css.map */ /* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .region.region-footer { background-color: #1E1E23; padding: 20px; text-align: center; } .region.region-footer .block { max-width: 1264px; margin: 10px auto; color: #dddddd; } .region.region-footer .block a { color: #dddddd; font-size: 17px; } .region.region-footer .block a:hover, .csnfooter.small:hover { color: #ffffff; } #footer-links span.sep { color: rgb(151, 174, 206); font-size: 8px; display: inline-block; margin: 0 10px; line-height: 18px; vertical-align: text-top; } .csnfooter.small { font-size: 13px; margin-bottom: 15px; text-align: center; } @media only screen and (min-width: 768px) { .csnfooter.small { width: calc(100% - 348px); } } /*# sourceMappingURL=styles.css.map */ <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-W7KNSFJ" height="0" width="0" style="display:none;visibility:hidden"></iframe>

Please remember that these discussion boards are a public forum, which means open to the public (i.e. non-CSN members) and the content can be found via internet search engines. Members are strongly advised not to share personal identifiers such as real names, email address, telephone number, street address, etc. This information can be used to identify you and link you to the content you provide. Other areas of CSN are restricted to members only and cannot be found by search engines.

Prostate Cancer

Archives for July 2008

Agressive recurrence
I am 55 and had the surgery to remove prostate in 2001. Gleaseon was 7 and T2 score. Up until last year I had a psa of 0. My wife and I moved from Oregon to FLorida to get more sunshine and since we were both cancer survivors we did it sooner than later. During a routine blood workup for my Type II diabetes, I noticed that…
PSA UP AGAIN
HAD RAD SURGERY IN 05 PSA AFTER 0.04 IN O7 PSA WENT TO 8.5 TOOK CASADEX AND LUPRON AND 39 RADIATION TREATMENS FINISHED IN FEB 08 MARCH 08 PSA WENT TO 0.07 WENT LAST WEEK PSA BACK UP AGAIN TO .74TOLD IT COULD BE BOUNCE FROM RADIATION PRESENTLY ON NOTHING SINCE LUPRON IN JAN 08 AND FINISHED RAADIATION IN MID FEB 08 HAVE TO…
HIFU
has anyone tried the high intensity frequency ultrasound procedure? is there any new information re. this? I understand trials are starting in the U.S. and it has been done in europe and canada.

/* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .footer { background: #f5f5f6; color: #555a62; font-size: 14px; line-height: 1.5; padding: 18px 0; } .footer-wrap { padding-left: 18px; padding-right: 18px; max-width: 1236px; margin: 0 auto; } .footer a { color: #0291db; } .footer a:hover { color: #0276b3; } .footer-row { display: flex; flex-wrap: wrap; justify-content: space-between; align-items: center; margin: -3px; } .footer-col { padding: 0 3px; } .footer-col-copyRight { justify-content: flex-start; } .footer-col-logo { justify-content: flex-end; } .footer-col-copyRight, .footer-col-logo { flex: 1; display: flex; } .logo { width: 120px; height: 28px; opacity: 0.6; } @media screen and (max-width: 768px) { .footer-row { display: block; } .footer-col { width: 100%; text-align: center; margin: 6px 0; } .footer-col:first-child { margin-top: 0; } .footer-col:last-child { margin-bottom: 0; } .footer-col-copyRight, .footer-col-logo { justify-content: center; } .logo { margin: 0 auto; } } /*# sourceMappingURL=styles.css.map */ /* * These styles apply ONLY to the header and footer assets. */ * { padding: 0; margin: 0; box-sizing: border-box; } .region.region-footer { background-color: #1E1E23; padding: 20px; text-align: center; } .region.region-footer .block { max-width: 1264px; margin: 10px auto; color: #dddddd; } .region.region-footer .block a { color: #dddddd; font-size: 17px; } .region.region-footer .block a:hover, .csnfooter.small:hover { color: #ffffff; } #footer-links span.sep { color: rgb(151, 174, 206); font-size: 8px; display: inline-block; margin: 0 10px; line-height: 18px; vertical-align: text-top; } .csnfooter.small { font-size: 13px; margin-bottom: 15px; text-align: center; } @media only screen and (min-width: 768px) { .csnfooter.small { width: calc(100% - 348px); } } /*# sourceMappingURL=styles.css.map */

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2023 © Cancer Survivors Network